Gilead shares rise after United States approves remdesivir as COVID-19 drug - Reuters UK
3:42am PDT - October 23rd, 2020 veterans day - ReutersShares of Gilead Sciences Inc rose 6% on Friday after its antiviral drug, remdesivir, became the first and only approved treatment for COVID-19 in the United States.